13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 64 holding rows worth $2,589,659,000.
- Accession
- 0001425738-18-000025
- Filer
- CIK 1425738
- Filed
- 2018-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 64 entries on the cover page, a total value of $2,589,659,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,589,659,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 17,224,428 | $281,103,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 4,236,017 | $165,205,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 10,738,658 | $161,509,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 9,702,482 | $102,070,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 3,204,343 | $96,066,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 2,237,607 | $89,728,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 6,505,766 | $82,623,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 636,900 | $78,708,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,095,612 | $74,556,000 | thousands by filing date | |
| WELLCARE HEALTH PLANS INC | 94946T106 | COM | 342,309 | $66,281,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 1,096,100 | $65,678,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 6,655,962 | $64,962,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 2,130,972 | $63,610,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 547,079 | $63,270,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 559,800 | $59,826,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 523,150 | $54,449,000 | thousands by filing date | |
| SYNEOS HEALTH INC | 87166B102 | CL A | 1,526,104 | $54,177,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 193,472 | $48,832,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 2,166,362 | $48,786,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 729,874 | $45,946,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 518,288 | $45,868,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 267,100 | $45,607,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 404,800 | $45,119,000 | thousands by filing date | |
| TELEFLEX INCORPORATED | 879369106 | COM | 176,586 | $45,026,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 1,308,526 | $39,321,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,955,565 | $38,393,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 2,282,268 | $37,041,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 2,011,989 | $35,713,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 145,420 | $31,120,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 2,469,687 | $30,748,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 1,182,393 | $26,426,000 | thousands by filing date | |
| NIGHTSTAR THERAPEUTICS PLC | 65413A101 | ADR | 1,768,946 | $25,420,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAB1 | NOTE 2.625%12/0 | 19,000,000 | $25,196,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 5,923,161 | $25,055,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 851,100 | $24,546,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339AA3 | NOTE 2.500% 2/0 | 25,000,000 | $23,090,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 1,652,240 | $21,446,000 | thousands by filing date | |
| PRA HEALTH SCIENCES INC | 69354M108 | COM | 245,314 | $20,351,000 | thousands by filing date | |
| VERADIGM INC | 01988P108 | COMMON STOCK | 1,626,900 | $20,092,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 3,728,690 | $19,389,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 238,600 | $19,193,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 1,330,495 | $19,039,000 | thousands by filing date | |
| HESKA CORP | 42805E306 | COM | 238,446 | $18,854,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 821,280 | $16,458,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 381,000 | $15,686,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 2,054,200 | $14,893,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 594,200 | $12,585,000 | thousands by filing date | |
| Armo Biosciences Inc | 04225U104 | COM | 298,800 | $11,178,000 | thousands by filing date | |
| TELADOC HEALTH INC | 87918A105 | COM | 273,200 | $11,010,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 2,139,520 | $10,034,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 334,680 | $9,522,000 | thousands by filing date | |
| MODEL N INC | 607525102 | COM | 523,937 | $9,457,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 67,500 | $7,993,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 40,000 | $6,720,000 | thousands by filing date | |
| PETIQ INC | 71639T106 | COMMON STOCK | 197,159 | $5,244,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 1,884,992 | $4,995,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 106,820 | $1,871,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 160,718 | $1,136,000 | thousands by filing date | |
| ISHARES TR | 464288828 | US HLTHCR PR ETF | 2,087 | $330,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 8,130 | $328,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 20,000 | $284,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 9,930 | $223,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 29,000 | $145,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 22,236 | $129,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001425738-18-000025 | this filing | 2018-05-15 | acceptance time not in the bulk data set |